Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.85 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.48 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.48 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | SNCA | P37840 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Naphthol SCHEMBL273260 | 0.92 | CYP1A2 (1.00) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL10486461 | 0.92 | CYP1A2 (1.00) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL3416 | 0.92 | CYP1A2 (1.00) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL29767730 | 0.92 | CYP1A2 (1.00) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL11247168 | 0.90 | CYP1A2 (0.94) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL8904232 | 0.90 | CYP1A2 (0.94) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL11295882 | 0.90 | CYP1A2 (0.94) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL21490911 | 0.90 | CYP1A2 (0.94) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL8219136 | 0.90 | CYP1A2 (0.94) | CYP1A2PTPN22IDO1KDM4EPLAU | |
| 1-Naphthol SCHEMBL9850314 | 0.90 | CYP1A2 (0.94) | CYP1A2PTPN22IDO1KDM4EPLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1559006-A | Methods and compositions for analyzing proteins | 埃克来拉生物科学公司 | 2004-12-29 | — | — | CN | claimed |
| US-20240228500-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2024-07-11 | — | — | US | disclosed |
| US-12029791-B2 | Therapeutic conjugates | TOTUS MEDICINES INC. (US) | 2024-07-09 | — | — | US | disclosed |
| EP-4308121-A1 | THERAPEUTIC CONJUGATES | Totus Medicines Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20230405135-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC (US) | 2023-12-21 | — | — | US | disclosed |
| EP-4210766-A1 | THERAPEUTIC CONJUGATES | Totus Medicines Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| CN-110431123-B | Laminated glass | 积水化学工业株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-110650929-B | Laminated glass | 积水化学工业株式会社 | 2023-04-07 | — | — | CN | disclosed |
| US-20230096658-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2023-03-30 | — | — | US | disclosed |
| US-20220387603-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2022-12-08 | — | — | US | disclosed |
| US-20200303044-A1 | Devices and Methods for Authenticating a Medical Test and Use of the Same | ESSENLIX CORPORATION (US) | 2020-09-24 | — | — | US | disclosed |
| CN-110832852-A | Photoelectric conversion element and adhesive | JSR株式会社 | 2020-02-21 | — | — | CN | disclosed |
| CN-110650929-A | Laminated glass | 积水化学工业株式会社 | 2020-01-03 | — | — | CN | disclosed |
| WO-2019075415-A1 | DEVICES AND METHODS FOR AUTHENTICATING A MEDICAL TEST AND USE OF THE SAME | ESSENLIX CORPORATION (US) | 2019-04-18 | — | — | WO | disclosed |
| US-20140255468-A1 | MODIFIED POLYNUCLEOTIDES ENCODING PROGRAMMED CELL DEATH 1 | MODERNA THERAPEUTICS, INC. (US) | 2014-09-11 | — | — | US | disclosed |
| US-20120071353-A1 | APPARATUS AND METHOD FOR PERFORMING NUCLEIC ACID ANALYSIS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| CN-101116857-A | Manufacturing method for thin film coating | NIPPON OILS & FATS CO LTD (JP) | 2008-02-06 | — | — | CN | disclosed |
| CN-1333388-C | Optical disc, its recording method, its recording device, its reproducing method, and its reproducing device | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2007-08-22 | — | — | CN | disclosed |
| CN-1441637-A | Compositions for repelling crawling insects | BAYER AG (DE) | 2003-09-10 | — | — | CN | disclosed |
| CN-1264485-A | Optical disc, its recording method, its recording device, its reproducing method, and its reproducing device | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2000-08-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029791-B2 | Therapeutic conjugates | CD47, CD44, EPCAM | CYP1A2 4587/4885PTPN22 887/4885IDO1 4317/4885 |
| US-20240228500-A1 | THERAPEUTIC CONJUGATES | CD47, CD44, EPCAM | CYP1A2 4587/4885PTPN22 887/4885IDO1 4317/4885 |
| US-20220387603-A1 | THERAPEUTIC CONJUGATES | CD47, CD44, EPCAM | CYP1A2 4587/4885PTPN22 887/4885IDO1 4317/4885 |
| US-20230405135-A1 | THERAPEUTIC CONJUGATES | CD47, CD44, EPCAM | CYP1A2 4587/4885PTPN22 887/4885IDO1 4317/4885 |
| US-20140255468-A1 | MODIFIED POLYNUCLEOTIDES ENCODING PROGRAMMED CELL DEATH 1 | MSH2, POLRMT, PDCD1 | CYP1A2 4863/4885PTPN22 1867/4885IDO1 2117/4885 |
| US-20230096658-A1 | THERAPEUTIC CONJUGATES | CD47, CD44, EPCAM | CYP1A2 4587/4885PTPN22 887/4885IDO1 4317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.